NeuroEPO

· University of Saskatchewan

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NeuroEPO, covering 2020-07-15 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]